TATA HEALTH (01255) announced its results for the six months ended June 30, 2024. The group recorded revenue of HK$72.309 million during the period, representing a decrease of 30.56% compared to the same period last year. The loss attributable to owners of the company was HK$5.13 million, which narrowed by 58.38% year-over-year. Basic loss per share was HK$0.02.